Detalhe da pesquisa
1.
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications.
Blood
; 136(20): 2334-2345, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32844992
2.
Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia.
J Cell Mol Med
; 24(5): 2968-2980, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31967735
3.
The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.
J Cell Mol Med
; 24(3): 2145-2156, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943762
4.
Inhibition of the deubiquitinase USP10 induces degradation of SYK.
Br J Cancer
; 122(8): 1175-1184, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015510
5.
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.
Cancer
; 125(4): 541-549, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30422308
6.
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.
Br J Haematol
; 187(4): 488-501, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309543
7.
Inhibition of USP10 induces degradation of oncogenic FLT3.
Nat Chem Biol
; 13(12): 1207-1215, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28967922
8.
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells.
Blood
; 127(9): 1138-50, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26675349
9.
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.
Blood
; 123(18): 2816-25, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574459
10.
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.
Blood Cancer Discov
; 5(3): 180-201, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442309
11.
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.
Blood
; 117(17): 4409-19, 2011 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321360
12.
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics.
Blood Cancer J
; 13(1): 23, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737429
13.
MicroRNAs 15a/16-1 function as tumor suppressor genes in multiple myeloma.
Blood
; 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20962322
14.
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants.
Blood
; 115(21): 4206-16, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20299508
15.
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
Leukemia
; 36(4): 1088-1101, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082402
16.
The dChip survival analysis module for microarray data.
BMC Bioinformatics
; 12: 72, 2011 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388547
17.
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.
Blood
; 112(13): 5111-21, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18815290
18.
The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma.
Leukemia
; 34(1): 167-179, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182781
19.
Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia.
Leukemia
; 34(9): 2543, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32144400
20.
Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia.
Cancer Cell
; 38(6): 872-890.e6, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217342